SCHEMBL14154751

SCHEMBL14154751

CCC1=C(CC)NCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17527173 0.80 — —
SCHEMBL26558286 0.70 — —
SCHEMBL22461598 0.70 — —
SCHEMBL30953663 0.64 — —
SCHEMBL13757871 0.61 — —
SCHEMBL24931066 0.60 — —
SCHEMBL24220645 0.60 — —
SCHEMBL249642 0.57 — —
SCHEMBL13360255 0.56 — —
SCHEMBL13207494 0.55 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2746285-A1 Process for the preparation of aurora kinase inhibitors MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-06-25 — — EP disclosed
WO-2008082484-A1 4,5-RING ANNULATED INDOLE DERIVATIVES FOR TREATING OR PREVENTING OF HCV AND RELATED VIRAL INFECTIONS SCHERING CORPORATION (US) 2008-07-10 — — WO disclosed
Send feedback